Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
1 clinical trials · Condition
◉ Watch Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis (NCT06374459) | Washington University School of Medicine | 2025-01-30 |
Track Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.